NO954146L - Belagte farmasöytiske preparater - Google Patents

Belagte farmasöytiske preparater

Info

Publication number
NO954146L
NO954146L NO954146A NO954146A NO954146L NO 954146 L NO954146 L NO 954146L NO 954146 A NO954146 A NO 954146A NO 954146 A NO954146 A NO 954146A NO 954146 L NO954146 L NO 954146L
Authority
NO
Norway
Prior art keywords
composition
pharmaceutical preparations
coated pharmaceutical
carboxamides
coated
Prior art date
Application number
NO954146A
Other languages
English (en)
Other versions
NO954146D0 (no
Inventor
Carmelita Macklin Russell
Allen I Dines
James Grigg Upson
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO954146L publication Critical patent/NO954146L/no
Publication of NO954146D0 publication Critical patent/NO954146D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasøytisk preparat som er egnet for belegging og som omfatter et preparat for oral administrering i enhetsdoseform og hvor dette preparat er blitt belagt med fra omtrent 0,01% til omtrent 10%, uttrykt i vekt av preparatet, av en flyktig aromatisk forbindelse som er valgt fra gruppen av 3-1-men- toksypropan-l,2-diol, N-substituerte p-mentan-3-karboksamider og acykliske karboksamider og blandinger derav.
NO954146A 1993-04-30 1995-10-18 Belagte farmasöytiske preparater NO954146D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5670193A 1993-04-30 1993-04-30
PCT/US1994/004089 WO1994025009A1 (en) 1993-04-30 1994-04-13 Coated pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO954146L true NO954146L (no) 1995-10-18
NO954146D0 NO954146D0 (no) 1995-10-18

Family

ID=22006081

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954146A NO954146D0 (no) 1993-04-30 1995-10-18 Belagte farmasöytiske preparater

Country Status (8)

Country Link
US (1) US5827852A (no)
EP (1) EP0695175A1 (no)
JP (1) JPH08509725A (no)
CN (1) CN1122103A (no)
CA (1) CA2161217A1 (no)
FI (1) FI955144A7 (no)
NO (1) NO954146D0 (no)
WO (1) WO1994025009A1 (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1655595A (en) * 1994-04-29 1995-11-09 Mcneil-Ppc, Inc. Solid pharmaceutical dosage form containing flavored film coating
US5698181A (en) * 1994-12-09 1997-12-16 Warner-Lambert Company Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same
GB9517031D0 (en) * 1995-08-19 1995-10-25 Procter & Gamble Confection compositions
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
AU3693397A (en) * 1996-07-10 1998-02-02 Novartis Consumer Health S.A. Oral pharmaceutical combinations of antihistaminic compounds and terpenoids
ZA976189B (en) * 1996-07-12 1999-01-11 Novartis Consumer Health Sa Oral pharmaceutical combinations
WO1998024455A1 (en) * 1996-12-06 1998-06-11 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
GB9706149D0 (en) * 1997-03-25 1997-05-14 Scherer Corp R P Comestible capsules having flavoured coatings
US6564945B1 (en) * 1997-07-14 2003-05-20 Robert E. Weinstein Medication assemblage for use in sinusitis treatment regimens
US6627233B1 (en) 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US6455080B1 (en) 1997-12-29 2002-09-24 Wm. Wrigley Jr., Company Chewing gum containing controlled release acyclic carboxamide and method of making
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
AU1607601A (en) * 1999-11-15 2001-05-30 J. Manheimer, Inc. Mint flavor and aroma compositions
CN1215837C (zh) * 2000-08-25 2005-08-24 兴和株式会社 布洛芬胶囊填充液和胶囊制剂
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
FR2822709B1 (fr) * 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US6887926B1 (en) 2001-11-16 2005-05-03 Oatey Co. Bonding compositions for chlorinated polymers and methods of using the same
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
DK1496752T3 (da) * 2002-04-19 2009-10-19 Wrigley W M Jun Co Tripel-coatet konfekturetabletprodukt
US20040033257A1 (en) * 2002-05-30 2004-02-19 Strides Inc. Pharmaceutical formulation in a drug delivery system and process for preparing the same
JP4320217B2 (ja) * 2002-07-10 2009-08-26 剤盛堂薬品株式会社 鼻炎用経口製剤
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
MXPA05009383A (es) * 2003-03-03 2005-11-04 Wrigley W M Jun Co Revestimiento de liberacion rapida de sabor para confiteria.
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
ES2396129T3 (es) * 2003-12-30 2013-02-19 Wm. Wrigley Jr. Company Producto de confitería recubierto
BRPI0508335B1 (pt) * 2004-02-26 2019-09-03 Wrigley W M Jun Co doces e goma de mascar contendo agentes refrescantes fisiológicos
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE IBUPROFEN ORAL DOSAGE FORMULATIONS, METHODS OF PREPARATION AND USE THEREOF
WO2007117704A2 (en) * 2006-04-07 2007-10-18 Michalis Nicolaou Pure isomers of tritoqualine
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
EP2526938A3 (en) * 2007-02-12 2013-06-12 Mike Nicolaou Histidine decarboxylase inhibitor sole or combined with a leukotriene receptor antagonist, an anti-H1 and/or an anti-H2 to treat COPD or gastrointestinal disorders.
US20080207593A1 (en) * 2007-02-28 2008-08-28 Collegium Pharmaceutical, Inc. Antihistamine Combination
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
CN101467988B (zh) * 2007-12-27 2014-07-09 北京德众万全医药科技有限公司 一种含有氨酚伪麻的药用组合物及其制备方法
EP3090743A1 (en) 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmaceutical compositions for treating headache and eliminating nausea
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
EP2760441A2 (en) 2011-09-27 2014-08-06 Virginia Commonwealth University Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactives
US9212290B2 (en) 2012-01-27 2015-12-15 Celanese Acetate Llc Substituted cellulose acetates and uses thereof
US9167830B2 (en) 2012-01-27 2015-10-27 Celanese Acetate Llc Substituted cellulose acetates and uses thereof
US9023757B2 (en) 2012-01-27 2015-05-05 Celanese Acetate Llc Substituted cellulose acetates and uses thereof
US9090045B2 (en) 2012-09-24 2015-07-28 Celanese Acetate Llc Engineered wood produced with substituted cellulose ester adhesives and methods relating thereto
WO2014046679A1 (en) 2012-09-24 2014-03-27 Celanese Acetate Llc Wood laminate articles comprising substituted cellulose ester adhesives and methods relating thereto
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015100312A1 (en) 2013-12-24 2015-07-02 Virginia Commonwealth University Uses of oxygenated cholesterol sulfates (ocs)
ES2809458T3 (es) 2014-07-17 2021-03-04 Pharmaceutical Manufacturing Res Services Inc Forma de dosificación llena de líquido, disuasoria del abuso y de liberación inmediata
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
EP3423041A4 (en) 2016-03-04 2019-09-11 Charleston Laboratories, Inc. PHARMACEUTICAL COMPOSITIONS
CA3043327C (en) 2016-11-14 2020-08-11 Mingwu Wang Ambroxol formulations for the treatment of ocular surface diseases and related methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515781A (en) * 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
US4136163A (en) * 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
GB1421743A (en) * 1972-04-18 1976-01-21 Wilkinson Sword Ltd Ingestible topical and other compositions
LU68016A1 (no) * 1973-07-13 1975-04-11
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
JPS61194049A (ja) * 1985-02-22 1986-08-28 Takasago Corp ｌ−メンチル３−ヒドロキシブチレ−ト，その製造法およびこれを有効成分とする冷感剤
EP0310299A1 (en) * 1987-09-28 1989-04-05 The Procter & Gamble Company Beta-amino acid ester derivatives of alcoholic actives having extended duration of activity
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet
KR100238565B1 (ko) * 1991-04-04 2000-02-01 데이비드 엠 모이어 상부 위장관 통증을 치료하기 위한 섭취가능한 약학적 조성물

Also Published As

Publication number Publication date
FI955144L (fi) 1995-10-31
US5827852A (en) 1998-10-27
NO954146D0 (no) 1995-10-18
FI955144A0 (fi) 1995-10-27
EP0695175A1 (en) 1996-02-07
WO1994025009A1 (en) 1994-11-10
JPH08509725A (ja) 1996-10-15
FI955144A7 (fi) 1995-10-31
CN1122103A (zh) 1996-05-08
CA2161217A1 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
NO954146L (no) Belagte farmasöytiske preparater
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE156835T1 (de) Neue 11-benzaldoximestradien-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE203902T1 (de) Fluorchlorkohlenwasserstofffreie aerosolformulierungen
DE59610280D1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
FI923691A7 (fi) Sykliset iminojohdokset, näitä yhdisteitä sisältävät farmaseuttiset seokset ja menetelmä niiden valmistamiseksi
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
AR018197A1 (es) Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
GT199700037A (es) Composiciones farmaceuticas para el tratamiento de la rinitis
FI943688L (fi) Uudet 11-bentsaldoksiimi-17beta-metoksi-27alfa-metoksi-metyyli-estradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä sisältävät lääkeaineet
FI951789A7 (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farma seuttiset koostumukset
NO980858L (no) Farmas÷ytiske preparater og anordninger for administrering derav
NO302368B1 (no) Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
DE3868309D1 (de) Imidazol-derivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammenstellungen und deren anwendung als arzneimittel.
GEP20032924B (en) Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
IT9019793A0 (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
FI940031L (fi) Uusia 2-syaani-3-hydroksipropenamidijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö lääkkeinä ja niitä sisältävät farmaseuttiset koostumukset
NO305560B1 (no) Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament
HUP9900863A3 (en) 4,4-(disubstituted)cyclohexan-1-ol derivatives pharmaceutical compositions containing these compounds and use thereof
DK0946585T3 (da) Steroidforbindelser substitueret i stilling 11, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
ZA943648B (en) Medicament aerosol formulation based on fusafungine a process for its preparation and pharmaceutical compositions containing it